Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1695-1699

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rohde, L. E. P.
Right arrow Articles by Lee, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rohde, L. E. P.
Right arrow Articles by Lee, R. T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Pathophysiology
Right arrow Growth factors/cytokines
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1695-1699.)
© 1999 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Plasma Concentrations of Interleukin-6 and Abdominal Aortic Diameter Among Subjects Without Aortic Dilatation

Luis E. P. Rohde; Luis H. Arroyo; Nader Rifai; Mark A. Creager; Peter Libby; Paul M. Ridker; Richard T. Lee

From the Cardiovascular Division, Brigham and Women's Hospital, and the Department of Laboratory Medicine, Children's Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Richard T. Lee, MD, Cardiovascular Division, Harvard Medical School, 75 Francis St, Boston, MA 02115. E-mail rtlee{at}bics.bwh.harvard.edu

Abstract—Previous studies suggest that cytokine-induced tissue inflammation may participate in the pathogenesis of abdominal aortic aneurysms. Serum inflammatory markers may reflect arterial inflammation in asymptomatic phases of the aneurysmal disease. We studied 120 outpatients (62 men; age, 65±9 years) by ultrasound evaluation of the abdominal aorta to evaluate the association of circulating levels of interleukin-6 (IL-6) with abdominal aortic diameter in subjects with normal aortic size. Aortic diameter was measured at the infrarenal level and indexed for body surface area. Seven patients with abdominal aortic dilatation (indexed aortic diameter, >1.3 cm/m2) were also identified. Plasma concentrations of IL-6, serum amyloid A (SAA), C-reactive protein (CRP), total homocysteine, and lipids were measured. Among the 113 subjects without aortic dilatation, indexed aortic diameter was positively associated with serum levels of IL-6 (P<0.01), SAA (P<0.01), and total homocysteine (P=0.01). IL-6 levels increased in a stepwise fashion among dichotomized groups of aortic size (low and high aortic diameters) and peaked in patients with aortic dilatation (2.3±1.2 versus 2.7±0.9 versus 3.2±0.9 pg/mL, respectively; P for trend=0.039). None of the serum lipid measurements correlated with abdominal aortic diameter. Although CRP levels were associated with SAA levels (r=0.60; P<0.001), associations between CRP and aortic diameter were nonsignificant. In multivariate analysis, levels of IL-6 (P=0.02), SAA (P=0.001), and total homocysteine (P<0.001) were independent correlates of indexed aortic diameter. In conclusion, circulating levels of IL-6, SAA, and total homocysteine may reflect processes involved in the early phases of abdominal aortic aneurysm formation, before dilation of the abdominal aorta is established. These data support a role for chronic inflammation in the progression of asymptomatic aortic disease.


Key Words: atherosclerosis • inflammation • aortic aneurysm • homocysteine




This article has been cited by other articles:


Home page
CirculationHome page
J. Golledge, P. S. Tsao, R. L. Dalman, and P. E. Norman
Circulating Markers of Abdominal Aortic Aneurysm Presence and Progression
Circulation, December 2, 2008; 118(23): 2382 - 2392.
[Full Text] [PDF]


Home page
CirculationHome page
M. Thomas, D. Gavrila, M. L. McCormick, F. J. Miller Jr, A. Daugherty, L. A. Cassis, K. C. Dellsperger, and N. L. Weintraub
Deletion of p47phox Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-Deficient Mice
Circulation, August 1, 2006; 114(5): 404 - 413.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Shimizu, R. N. Mitchell, and P. Libby
Inflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms
Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 987 - 994.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Makita, M. Nakamura, and K. Hiramori
The Association of C-Reactive Protein Levels With Carotid Intima-Media Complex Thickness and Plaque Formation in the General Population
Stroke, October 1, 2005; 36(10): 2138 - 2142.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Norman, C. A. Spencer, M. M. Lawrence-Brown, and K. Jamrozik
C-Reactive Protein Levels and the Expansion of Screen-Detected Abdominal Aortic Aneurysms in Men
Circulation, August 17, 2004; 110(7): 862 - 866.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. P. Faxon, V. Fuster, P. Libby, J. A. Beckman, W. R. Hiatt, R. W. Thompson, J. N. Topper, B. H. Annex, J. H. Rundback, R. P. Fabunmi, et al.
Atherosclerotic Vascular Disease Conference: Writing Group III: Pathophysiology
Circulation, June 1, 2004; 109(21): 2617 - 2625.
[Full Text] [PDF]


Home page
CirculationHome page
M. A. Creager, D. W. Jones, J. D. Easton, J. L. Halperin, A. T. Hirsch, A. H. Matsumoto, P. T. O'Gara, R. D. Safian, G. L. Schwartz, and J. A. Spittell
Atherosclerotic Vascular Disease Conference: Writing Group V: Medical Decision Making and Therapy
Circulation, June 1, 2004; 109(21): 2634 - 2642.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Engstrom, G. Borner, B. Lindblad, L. Janzon, and F. Lindgarde
Incidence of Fatal or Repaired Abdominal Aortic Aneurysm in Relation to Inflammation-Sensitive Plasma Proteins
Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 337 - 341.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
Y. Agmon, B. K. Khandheria, I. Meissner, G. L. Schwartz, J. D. Sicks, A. J. Fought, W. M. O'Fallon, D. O. Wiebers, and A. J. Tajik
Is aortic dilatation an atherosclerosis-related process?: Clinical, laboratory, and transesophageal echocardiographiccorrelates of thoracic aortic dimensions in the populationwith implications for thoracic aortic aneurysm formation
J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1076 - 1083.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. G. Deng, B. Martin-McNulty, D. A. Sukovich, A. Freay, M. Halks-Miller, T. Thinnes, D. J. Loskutoff, P. Carmeliet, W. P. Dole, and Y.-X. Wang
Urokinase-Type Plasminogen Activator Plays a Critical Role in Angiotensin II-Induced Abdominal Aortic Aneurysm
Circ. Res., March 21, 2003; 92(5): 510 - 517.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y.-X. Wang, B. Martin-McNulty, A. D. Freay, D. A. Sukovich, M. Halks-Miller, W.-W. Li, R. Vergona, M. E. Sullivan, J. Morser, W. P. Dole, et al.
Angiotensin II Increases Urokinase-Type Plasminogen Activator Expression and Induces Aneurysm in the Abdominal Aorta of Apolipoprotein E-Deficient Mice
Am. J. Pathol., October 1, 2001; 159(4): 1455 - 1464.
[Abstract] [Full Text]


Home page
CirculationHome page
K.G. Jones, D.J. Brull, L.C. Brown, M. Sian, R.M. Greenhalgh, S.E. Humphries, and J.T. Powell
Interleukin-6 (IL-6) and the Prognosis of Abdominal Aortic Aneurysms
Circulation, May 8, 2001; 103(18): 2260 - 2265.
[Abstract] [Full Text] [PDF]